Avacta (AVCT LN)

Avacta Group plc researches, develops, produces, and delivers instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology in the United Kingdom and internationally. It operates through two segments, Animal Health and Life Sciences. The Animal Health segment provides tools and contract services to assist the diagnosis of conditions in animals to enable treatment for veterinarians. The Life Sciences segment offers reagents and arrays for diagnostics, drugs, and biomarkers discovery in biotech research and development. The company was incorporated in 2003 and is based in Wetherby, the United Kingdom.